Liraglutide Research & Studies
We track 20 published, PubMed-indexed studies for Liraglutide, spanning 2014 to 2025. The research below includes 7 clinical trials, 11 reviews, 2 meta-analysiss.
These summaries are for educational purposes. Research findings, particularly from preclinical studies, may not translate to human outcomes. Always consult a qualified healthcare provider before making decisions based on this information.
7
Clinical Trials
11
Reviews
2
Meta-Analysiss
A randomized, double-blind, placebo-controlled trial of weight loss using liraglutide 3.0 mg for weight recurrence after Roux-en-Y gastric bypass.
Clinical TrialLofton HF, Maranga G, et al.|Surg Obes Relat Dis|2025
Metabolic resilience: liraglutide's potential in alleviating depressive symptoms.
ReviewGammoh O, Qnais E, et al.|Mol Biol Rep|2025
Liraglutide in Obese or Overweight Individuals With Stable Bipolar Disorder.
Clinical TrialMcElroy SL, Guerdjikova AI, et al.|J Clin Psychopharmacol|2024
Liraglutide innovations: a comprehensive review of patents (2014-2024).
ReviewPandey A, Goyal AK|Pharm Pat Anal|2024
Liraglutide Improves Diabetic Cardiomyopathy by Downregulation of Cardiac Inflammatory and Apoptosis Markers.
ReviewGupta P, Ekbbal R|Curr Drug Res Rev|2024
Liraglutide monotherapy and add on therapy on obese women with polycystic ovarian syndromes: a systematic review and meta-analysis.
Meta-AnalysisTian D, Chen W, et al.|Minerva Med|2022
Effects of liraglutide on gastrointestinal functions and weight in obesity: A randomized clinical and pharmacogenomic trial.
Clinical TrialMaselli D, Atieh J, et al.|Obesity (Silver Spring)|2022
Liraglutide pharmacokinetics and exposure-response in adolescents with obesity.
Meta-AnalysisCarlsson Petri KC, Hale PM, et al.|Pediatr Obes|2021
Efficacy and safety of once-weekly semaglutide 1.0mg vs once-daily liraglutide 1.2mg as add-on to 1-3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10).
Clinical TrialCapehorn MS, Catarig AM, et al.|Diabetes Metab|2020
Liraglutide for the Treatment of Obesity: Analyzing Published Reviews.
ReviewPastor R, Tur JA|Curr Pharm Des|2019
Cardiovascular Effects of Liraglutide.
ReviewMikhail N|Curr Hypertens Rev|2019
Liraglutide and its Neuroprotective Properties-Focus on Possible Biochemical Mechanisms in Alzheimer's Disease and Cerebral Ischemic Events.
ReviewWiciński M, Socha M, et al.|Int J Mol Sci|2019
Liraglutide for the prevention of major adverse cardiovascular events in diabetic patients.
ReviewMadsbad S|Expert Rev Cardiovasc Ther|2019
Liraglutide for psychiatric disorders: clinical evidence and challenges.
ReviewCamkurt MA, Lavagnino L, et al.|Horm Mol Biol Clin Investig|2018
Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial.
Clinical TrialNylander M, Frøssing S, et al.|Reprod Biomed Online|2017
Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial.
Clinical TrialMathieu C, Zinman B, et al.|Diabetes Care|2016
Liraglutide for treating type 1 diabetes.
ReviewDejgaard TF, Frandsen CS, et al.|Expert Opin Biol Ther|2016
Liraglutide: a review of its use in the management of obesity.
ReviewScott LJ|Drugs|2015
Liraglutide: A New Option for the Treatment of Obesity.
ReviewNuffer WA, Trujillo JM|Pharmacotherapy|2015
Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults.
Clinical Trialvan Can J, Sloth B, et al.|Int J Obes (Lond)|2014